The total return over the past 12 months is -45.53% vs. +16.94% for the S&P 500. So far it's up -28.19% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (45.53%) | +16.27% | (5.37%) | N/A | N/A | N/A |
| Total Return CAGR | (45.53%) | +16.27% | (5.37%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Tiziana Life Sciences Ltd (TLSA)
| Year | Start price | End price | TLSA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.49 | $1.07 | (28.19%) | +14.51% | (42.70%) |
| 2025 | $0.70 | $1.49 | +114.02% | +17.72% | +96.30% |
| 2024 | $0.56 | $0.70 | +24.32% | +24.89% | (0.57%) |
| 2023 | $0.60 | $0.56 | (6.67%) | +26.19% | (32.86%) |
| 2022 | $0.96 | $0.60 | (37.50%) | (18.17%) | (19.33%) |
| 2021 | $2.02 | $0.96 | (52.48%) | +28.74% | (81.22%) |
| 2020 | $2.70 | $2.02 | (25.19%) | +18.37% | (43.56%) |
| 2019 | $3.72 | $2.70 | (27.42%) | +31.22% | (58.64%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
